Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
22.41
-1.19 (-5.04%)
At close: Apr 24, 2026, 4:00 PM EDT
22.83
+0.42 (1.87%)
After-hours: Apr 24, 2026, 4:46 PM EDT
Lyell Immunopharma Employees
Lyell Immunopharma had 300 employees as of December 31, 2024. The number of employees increased by 76 or 33.93% compared to the previous year.
Employees
300
Change (1Y)
76
Growth (1Y)
33.93%
Revenue / Employee
$120
Profits / Employee
-$914,827
Market Cap
522.79M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 300 | 76 | 33.93% | 300 | 0 |
| Dec 31, 2023 | 224 | -50 | -18.25% | 224 | 0 |
| Dec 31, 2022 | 274 | 55 | 25.11% | 274 | 0 |
| Dec 31, 2021 | 219 | 29 | 15.26% | 219 | 0 |
| Mar 31, 2021 | 190 | - | - | 188 | 2 |
| Dec 31, 2020 | 190 | - | - | 188 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| ADC Therapeutics | 193 |
| Verastem | 102 |
| enGene Therapeutics | 82 |
| Upstream Bio | 75 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
| Fulcrum Therapeutics | 55 |
LYEL News
- 12 days ago - Lyell Immunopharma Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results - GlobeNewsWire
- 6 weeks ago - Lyell Immunopharma Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 6 weeks ago - Lyell Immunopharma Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer - GlobeNewsWire
- 7 weeks ago - Lyell Immunopharma Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Lyell Immunopharma Announces Participation in March Investor Conferences - GlobeNewsWire